Zunsemetinib (ATI-450) Emerging Drug Insights and Market Forecasts, 2032
April 13, 2023 10:33 ET
|
Research and Markets
Dublin, April 13, 2023 (GLOBE NEWSWIRE) -- The "Zunsemetinib (ATI-450) Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.The report...
UPLIZNA for Generalized Myasthenia Gravis (gMG) Emerging Drug Insights, Sales and Market Forecasts, 2019-2023 & 2024-2032
March 31, 2023 06:38 ET
|
Research and Markets
Dublin, March 31, 2023 (GLOBE NEWSWIRE) -- The "UPLIZNA Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
Global Enzyme Inhibitor Markets, Analysis & Forecasts, 2016-2021, 2021-2026F, 2031F: Focus on PPIs, Protease, Reverse Transcriptase, Aromatase, Kinase, Neuraminidase, & Statins
October 18, 2022 06:33 ET
|
Research and Markets
Dublin, Oct. 18, 2022 (GLOBE NEWSWIRE) -- The "Enzyme Inhibitor Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global enzyme inhibitor market is expected...
Protein Kinase Inhibitors in Oncology Analysis Service 2022: Must have Handbook for Any Business Developer, BI/CI Operative or Clinical Developer
June 15, 2022 07:58 ET
|
Research and Markets
Dublin, June 15, 2022 (GLOBE NEWSWIRE) -- The "Protein Kinase Inhibitors in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering.Protein Kinase Inhibitors in...
Tyrokinse Kinase Inhibitors in the Global Oncology Market 2021: Market Leaders by Indication and Product
November 05, 2021 05:58 ET
|
Research and Markets
Dublin, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The "Oncology Markets for Tyrokinse Kinase Inhibitors" report has been added to ResearchAndMarkets.com's offering. Traditional cancer therapy has focused...
Global High Throughput Screening (HTS) Markets 2021-2027: Resolving Technical Limitations - The Cornerstone for Future Success of Cell-based HTS
August 19, 2021 05:58 ET
|
Research and Markets
Dublin, Aug. 19, 2021 (GLOBE NEWSWIRE) -- The "High Throughput Screening (HTS) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global High...
Anaplastic Lymphoma Kinase ALK Inhibitors Market, 2026
August 10, 2021 04:48 ET
|
Research and Markets
Dublin, Aug. 10, 2021 (GLOBE NEWSWIRE) -- The "Global Anaplastic Lymphoma Kinase ALK Inhibitors Market, Drug Sales, Price & Clinical Trials Insight 2026" report has been added to...
Global Kinase Inhibitors Market Report 2021-2026Featuring Major Players - Pfizer, Novartis, AstraZeneca, Bayer, Eisai and Johnson & Johnson
July 02, 2021 08:08 ET
|
Research and Markets
Dublin, July 02, 2021 (GLOBE NEWSWIRE) -- The "Global Kinase Inhibitors Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for kinase inhibitors should...
Insights on the Anaplastic Lymphoma Kinase ALK Inhibitors Global Market to 2026 - Lorbrena Overcomes Xalkori as Front-Line Therapy in NSCLC
April 21, 2021 04:58 ET
|
Research and Markets
Dublin, April 21, 2021 (GLOBE NEWSWIRE) -- The "Global Anaplastic Lymphoma Kinase ALK Inhibitors Market, Drug Sales, Price & Clinical Trials Insight 2026" report has been added to...
$1.7 Billion Recombinant Proteins Markets, 2021-2026 - Increasing Focus on Biomarker Discovery
March 05, 2021 05:43 ET
|
Research and Markets
Dublin, March 05, 2021 (GLOBE NEWSWIRE) -- The "Global Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery &...